Emyria |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 11 November 2026 at 10:32pm | ||||
|
Market Cap (11-Nov) $29,847,382 (923rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 0 |
Shortsold (5-Nov) 161,639 (0.02%) (562nd) |
|
52w High $0.070 |
52w Low $0.036 |
P/E - |
EPS -0.01 |
Change of Director's Interest Notice
EMD released this announcement to the ASX on 28 November 2022, 8:15. The announcement is not marked as price sensitive, and is 2 page(s) in length and 241.34kb in size.
You can view all announcements from EMD and see how they appear on a price chart on the announcements page.
At the date of this announcement, EMD was 0.086% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 562nd as of the latest reported data (05 November 2026).
| Other Recent Announcements from EMD | |
|---|---|
| Trading Halt | 29 June 2023, 9:33 |
| Emyria Receives Ethics Approval for MDMA-assisted Therapy | 8 June 2023, 9:10 |
| Section 708A(5)(e) Notice | 10 May 2023, 18:37 |
| Change of Director's Interest Notice | 28 November 2022, 8:15 |
| Notification regarding unquoted securities - EMD | 25 November 2022, 12:16 |
| Notification regarding unquoted securities - EMD | 25 November 2022, 12:09 |
| Placement completion and secondary trading notice | 23 November 2022, 10:00 |
If you were already registered, log in here.